Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients

This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>...

Full description

Bibliographic Details
Main Authors: Krzysztof Bonek, Ewa Kuca Warnawin, Anna Kornatka, Magdalena Plebańczyk, Tomasz Burakowski, Włodzimierz Maśliński, Małgorzata Wisłowska, Piotr Głuszko, Marzena Ciechomska
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/4/893
_version_ 1797436776275509248
author Krzysztof Bonek
Ewa Kuca Warnawin
Anna Kornatka
Magdalena Plebańczyk
Tomasz Burakowski
Włodzimierz Maśliński
Małgorzata Wisłowska
Piotr Głuszko
Marzena Ciechomska
author_facet Krzysztof Bonek
Ewa Kuca Warnawin
Anna Kornatka
Magdalena Plebańczyk
Tomasz Burakowski
Włodzimierz Maśliński
Małgorzata Wisłowska
Piotr Głuszko
Marzena Ciechomska
author_sort Krzysztof Bonek
collection DOAJ
description This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>n</i> = 25, RA <i>n</i> = 15) and 25 healthy controls (HC) were enrolled into the study. The expression of miR-223-5p, miR-92b-3p, miR-485-3p, miR-10b-5p, let-7d-5p, miR-26a-2-3p, miR-146b-3p, and cytokines levels were measured in sera. DIANA-mirPath analysis was used to predict pathways targeted by the dysregulated miRs. Disease activity scores were calculated. Lipid profile, uric acid, glucose level, and C-reactive protein (CRP) concentrations were determined in the blood. Based on lipid profiles, the PsA group had hypertriglyceridaemia, and RA patients revealed mixed dyslipidaemia, while in AS, no specific changes were found. miR expression analysis revealed upregulation of miR-26a-2-3p and miR-10b-5p in PsA, miR-485-3p in AS, and let-7d-5p in RA. Several correlations between disease activity indexes, metabolites levels, and expression of miRs were observed in PsA, RA, and AS patients. Finally, in ROC analysis, miR-26a-2-3p/miR-485-3p, and let-7d-5p/miR-146b-3p tandems revealed high sensitivity and specificity in distinguishing between PsA, AS, and RA. Our study illustrates the superiority of miR expressions in distinguishing between RA, PsA, and AS. In PsA, a unique regulatory pathway exists through miR-26a-2-3p, miR-223-5p, miR-10b-5p, and miR-92b-3p that converges proatherogenic metabolism and disease activity.
first_indexed 2024-03-09T11:07:29Z
format Article
id doaj.art-c820b100d9fb42f2b99caa6adedd09fd
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T11:07:29Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-c820b100d9fb42f2b99caa6adedd09fd2023-12-01T00:54:59ZengMDPI AGBiomedicines2227-90592022-04-0110489310.3390/biomedicines10040893Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis PatientsKrzysztof Bonek0Ewa Kuca Warnawin1Anna Kornatka2Magdalena Plebańczyk3Tomasz Burakowski4Włodzimierz Maśliński5Małgorzata Wisłowska6Piotr Głuszko7Marzena Ciechomska8Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandThis study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>n</i> = 25, RA <i>n</i> = 15) and 25 healthy controls (HC) were enrolled into the study. The expression of miR-223-5p, miR-92b-3p, miR-485-3p, miR-10b-5p, let-7d-5p, miR-26a-2-3p, miR-146b-3p, and cytokines levels were measured in sera. DIANA-mirPath analysis was used to predict pathways targeted by the dysregulated miRs. Disease activity scores were calculated. Lipid profile, uric acid, glucose level, and C-reactive protein (CRP) concentrations were determined in the blood. Based on lipid profiles, the PsA group had hypertriglyceridaemia, and RA patients revealed mixed dyslipidaemia, while in AS, no specific changes were found. miR expression analysis revealed upregulation of miR-26a-2-3p and miR-10b-5p in PsA, miR-485-3p in AS, and let-7d-5p in RA. Several correlations between disease activity indexes, metabolites levels, and expression of miRs were observed in PsA, RA, and AS patients. Finally, in ROC analysis, miR-26a-2-3p/miR-485-3p, and let-7d-5p/miR-146b-3p tandems revealed high sensitivity and specificity in distinguishing between PsA, AS, and RA. Our study illustrates the superiority of miR expressions in distinguishing between RA, PsA, and AS. In PsA, a unique regulatory pathway exists through miR-26a-2-3p, miR-223-5p, miR-10b-5p, and miR-92b-3p that converges proatherogenic metabolism and disease activity.https://www.mdpi.com/2227-9059/10/4/893miRNApsoriatic arthritisrheumatoid arthritisankylosing spondylitisinflammationlipids
spellingShingle Krzysztof Bonek
Ewa Kuca Warnawin
Anna Kornatka
Magdalena Plebańczyk
Tomasz Burakowski
Włodzimierz Maśliński
Małgorzata Wisłowska
Piotr Głuszko
Marzena Ciechomska
Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
Biomedicines
miRNA
psoriatic arthritis
rheumatoid arthritis
ankylosing spondylitis
inflammation
lipids
title Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
title_full Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
title_fullStr Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
title_full_unstemmed Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
title_short Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
title_sort circulating mirna correlates with lipid profile and disease activity in psoriatic arthritis rheumatoid arthritis and ankylosing spondylitis patients
topic miRNA
psoriatic arthritis
rheumatoid arthritis
ankylosing spondylitis
inflammation
lipids
url https://www.mdpi.com/2227-9059/10/4/893
work_keys_str_mv AT krzysztofbonek circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT ewakucawarnawin circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT annakornatka circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT magdalenaplebanczyk circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT tomaszburakowski circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT włodzimierzmaslinski circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT małgorzatawisłowska circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT piotrgłuszko circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients
AT marzenaciechomska circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients